Markers of Mitochondrial Metabolism in Tumor Hypoxia, Systemic Inflammation, and Adverse Outcome of Rectal Cancer
Tumor hypoxia contributes to therapy resistance and metastatic progression of locally advanced rectal cancer (LARC). We postulated that the tumor mitochondrial metabolism, manifested by reactive oxygen species (ROS) and mitochondrial DNA (mtDNA) damage, reflects how hypoxic conditions connect to can...
Main Authors: | Paula A. Bousquet, Sebastian Meltzer, Linda Sønstevold, Ying Esbensen, Svein Dueland, Kjersti Flatmark, Beathe Sitter, Tone Frost Bathen, Therese Seierstad, Kathrine Røe Redalen, Lars Eide, Anne Hansen Ree |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-01-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523318302572 |
Similar Items
-
Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high-resolution magic angle spinning <sup>1</sup>H magnetic resonance spectroscopy
by: Flatmark Kjersti, et al.
Published: (2008-04-01) -
High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer
by: Hanna Abrahamsson, et al.
Published: (2019-05-01) -
Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer
by: Sebastian Meltzer, et al.
Published: (2019-08-01) -
Biomarkers of Treatment Toxicity in Combined-Modality Cancer Therapies with Radiation and Systemic Drugs: Study Design, Multiplex Methods, Molecular Networks
by: Anne Hansen Ree, et al.
Published: (2014-12-01) -
Sex disparities in vitamin D status and the impact on systemic inflammation and survival in rectal cancer
by: Hanna Abrahamsson, et al.
Published: (2021-05-01)